1. Home
  2. |Insights
  3. |COVID-19 Development – CDC Issues New Recommendations for Fully Vaccinated Individuals

COVID-19 Development – CDC Issues New Recommendations for Fully Vaccinated Individuals

Client Alert | 3 min read | 05.14.21

CDC Interim Public Health Recommendations for Fully Vaccinated People

On May 13, 2021, the Centers for Disease Control and Prevention (CDC) revised its Interim Public Health Recommendations for Fully Vaccinated People.  Since the CDC’s April 27, 2021, guidance for vaccinated people, which Crowell & Moring summarized here, the CDC has loosened its recommendations for individuals who are fully vaccinated.  The key changes are that (1) fully vaccinated people no longer need to wear a mask or physically distance in any setting, except where required by federal, state, local, tribal, or territorial laws, rules, and regulations, including local business and workplace guidance; and (2) fully vaccinated people need not take a COVID test following a known exposure, unless they are residents or employees of a correctional or detention facility or a homeless shelter.

Who is Fully Vaccinated?

The CDC considers a person to be fully vaccinated beginning two weeks after they have received the second dose in a 2-dose series (Pfizer-BioNTech or Moderna), or beginning two weeks after they have received a single-dose vaccine (Johnson and Johnson [J&J]/Janssen).  Qualifying vaccines are the COVID-19 vaccines currently authorized for emergency use by the U.S. Food and Drug Administration—Pfizer-BioNTech, Moderna, and Johnson and Johnson (J&J)/Janssen COVID-19 vaccines—or COVID-19 vaccines that have been authorized for emergency use by the World Health Organization (e.g., AstraZeneca/Oxford).  There is currently no post-vaccination time limit on fully vaccinated status.

What is the General Guidance for Vaccinated People?

The CDC has recognized that indoor and outdoor activities pose a minimal risk to fully vaccinated people and have a reduced risk of transmitting COVID-19 to unvaccinated people.  The CDC now recommends the following for fully vaccinated people:

  • Fully vaccinated people should still get tested if experiencing COVID-19 symptoms
  • Fully vaccinated people should not visit private or public settings if they have tested positive for COVID-19 in the prior 10 days or are experiencing COVID-19 symptoms.
  • Fully vaccinated people should continue to follow any applicable federal, state, local, tribal, or territorial laws, rules, and regulations.

The CDC still recommends prevention measures for unvaccinated people, including social distancing and wearing a mask.

What Travel Restrictions Exist for Vaccinated People?

In general, all travelers must continue to wear a mask on planes, buses, trains, and any other forms of public transportation traveling into, within, or out of the United States and in U.S. transportation hubs such as airports and stations.  While the CDC has lessened its travel restrictions, as detailed below, travelers must also comply with local, state, and territorial testing and quarantine requirements. 

For domestic travel, fully vaccinated people are not required to get a COVID-19 test before or after domestic travel.  Fully vaccinated travelers do not need to self-quarantine.

For international travel, fully vaccinated people are still required to have a negative COVID-19 test or documentation of recovery before they board a flight to the United States.  And, the CDC still recommends that all travelers get a COVID-19 test three to five days after travel.  However, fully vaccinated travelers are no longer required by the CDC to get tested before leaving the United States nor do they have to self-quarantine after travel.

Insights

Client Alert | 6 min read | 03.26.24

California Office of Health Care Affordability Notice Requirement for Material Change Transactions Closing on or After April 1, 2024

Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur....